16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Low-molecular-weight heparin (LMWH) is cleared predominantly by the kidneys and hence there is uncertainty about the safety of its use in hemodialysis (HD) patients. Our primary objective was to compare whether tinzaparin and dalteparin differentially accumulate in HD patients.

          Related collections

          Author and article information

          Journal
          Am. J. Kidney Dis.
          American journal of kidney diseases : the official journal of the National Kidney Foundation
          Elsevier BV
          1523-6838
          0272-6386
          Sep 2012
          : 60
          : 3
          Affiliations
          [1 ] The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. mrodger@ohri.ca
          Article
          S0272-6386(12)00528-8
          10.1053/j.ajkd.2012.01.020
          22480794
          695b25f2-fc21-4b0e-827c-4b01af0417ed
          History

          Comments

          Comment on this article